Status:  Investigation


Acquirer:             Dassault Systèmes SE (France)

Acquired:            Medidata Solutions, Inc. (US)

Value:                   Approx. US$5.8 Billion

Industry:              Software; Life Sciences


On August 19, 2019, France based 3D design and engineering software company Dassault Systèmes SE (Euronext Paris: #13065, DSY. PA) and Medidata Solutions, Inc., a U.S. based life sciences software developer (NASDAQ: MDSO) “announced that Medidata stockholders have approved on August 16, 2019 the proposed acquisition of Medidata by Dassault Systèmes.”  (Joint Press Release, Medidata Solutions, Inc., Form 8-K, Ex-99.1, August 19, 2019, SEC Filing.)  “Completion of the acquisition is expected during the third or fourth quarter of 2019 and is subject to clearance by the Committee on Foreign Investment in the United States and other customary closing conditions.”  (Id.)  “On July 26, 2019, the [Medidata Solutions] and Dassault Systèmes submitted a joint voluntary notice for review by the Committee on Foreign Investment in the United States (“CFIUS”), which CFIUS accepted for review by letter dated August 8, 2019.”  (Medidata Solutions, Inc., Form 8-K, August 19, 2019, SEC Filing.) On September 24, 2019, Dassault Systèmes SE “announced that the Committee on Foreign Investment in the United States (CFIUS) will initiate an additional 45 calendar day examination for the proposed acquisition of Medidata by Dassault Systèmes.”  (Medidata Solutions, Inc., Form 8-K, Ex-99.1, September 24, 2019, SEC Filing.)